Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaScience & Research FDA Grants Fast Track Designation to Healx NF1 Treatment
FeaturedFeatured EUNF1PharmaPress Release FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug for NF1 Patients
Featured EUGlobalPharma Nathalie Moll, Director General of EFPIA, Delivered the Opening Address at the Global NF Conference
FeaturedPharmaScience & ResearchTop Story EU Innovative Health Initiative Highlights CTF’s Game-Changing Platform Trials